Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007;24(1):71-5.
doi: 10.1007/BF02685905.

A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer

Fukuto Maruta  1 , Satoshi Ishizone, Manabu Hiraguri, Yoshiro Fujimori, Fumiaki Shimizu, Shigeyoshi Kumeda, Shinichi Miyagawa
Affiliations
Randomized Controlled Trial

A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer

Fukuto Maruta et al. Med Oncol. 2007.

Abstract

We conducted a clinical pilot study to evaluate the efficacy and safety of the combination of docetaxel and 5'DFUR as a second-line chemotherapy for gastric cancer. Twenty-four patients were divided into two groups by simple randomization: group A (60 mg/m2 of docetaxel, every 3 wk) and group B (regimen A + 600 mg/body of 5'DFUR). The response rate was 17% and 42% in group A and B, respectively (p < 0.05). The MST from the start of the first-line was 17 mo in group B. The major adverse event was leukopenia in both groups.

PubMed Disclaimer

References

    1. Anticancer Res. 2005 Jul-Aug;25(4):2973-7 - PubMed
    1. Med Oncol. 2005;22(2):153-60 - PubMed
    1. Clin Oncol (R Coll Radiol). 2005 Apr;17(2):81-90 - PubMed
    1. Cancer. 1993 Jul 1;72(1):37-41 - PubMed
    1. Chemotherapy. 2006;52(6):301-7 - PubMed

Publication types

LinkOut - more resources